The purpose of this study is to determine whether in vivo administration of interleukin-12 (IL-12) will shift cytokine expression during T-independent immune responses and enhance the effectiveness of vaccination against polysaccharide antigens. IL-12 may be especially beneficial for enhancing the usefulness of pneumococcal and meningococcal polysaccharide vaccines, since it stimulates production of interferon-gamma and increases secretion of antibody isotypes that are efficient in mediating anti-bacterial immunity. For the experiments in this study, BALB/c and C57BL/6 mice will be inoculated with IL-12 and polysaccharide vaccine, and levels of induced cytokines and antibodies will be monitored at various times thereafter. The ability of IL-12 to cause shifts in cytokine RNA expression will be examined by RT-PCR and ribonuclease protection assays. The levels and specificities of induced antibodies will be quantitated using isotype-specific ELISAs. Intermediary cytokines potentially responsible for the observed effects will be identified using mice with targeted disruptions in cytokine genes and the role of endogenous IL-12 in regulating responsiveness will be examined using IL-12 knockout mice. Immunodeficient mice lacking specific lymphoid cell subsets will be exploited to determine whether the effect of IL-12 are due to activated NK cells or to direct stimulation of B-cells through binding to the newly described B-cell IL-12 receptor. The biological functions of the induced antibodies will be determined by complement fixation and opsonization assays against the target bacterial strains. Finally, the ability of IL-12 to enhance in vivo protection against lethal pneumococcal and meningococcal infections will be tested by direct inoculation of virulent bacterial strains into vaccinated mice. Infections due to S. pneumonia and N. meningitidis are the leading causes of pneumonia, meningitis, and otitis media, causing an estimated 7.5 million cases/year in the U.S. and over 100 million cases/year worldwide. Current vaccines are of only limited effectiveness. Thus, the use of IL-12 as a vaccine adjuvant may provide a novel approach for protection against these diseases and could have immediate impact on human health.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI041715-02
Application #
2856073
Study Section
Immunological Sciences Study Section (IMS)
Program Officer
Quill, Helen R
Project Start
1998-01-01
Project End
1999-04-16
Budget Start
1999-01-01
Budget End
1999-04-16
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Toledo
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
807418939
City
Toledo
State
OH
Country
United States
Zip Code
43614
Furuya, Yoichi; Kirimanjeswara, Girish S; Roberts, Sean et al. (2017) Defective anti-polysaccharide IgG vaccine responses in IgA deficient mice. Vaccine 35:4997-5005
Nguyen, Quang-Tam; Furuya, Yoichi; Roberts, Sean et al. (2015) Role of Interleukin-12 in Protection against Pulmonary Infection with Methicillin-Resistant Staphylococcus aureus. Antimicrob Agents Chemother 59:6308-16
Furuya, Yoichi; Furuya, Andrea K M; Roberts, Sean et al. (2015) Prevention of Influenza Virus-Induced Immunopathology by TGF-? Produced during Allergic Asthma. PLoS Pathog 11:e1005180
Blutt, S E; Miller, A D; Salmon, S L et al. (2012) IgA is important for clearance and critical for protection from rotavirus infection. Mucosal Immunol 5:712-9
Hickey, Anthony J; Hazlett, Karsten R O; Kirimanjeswara, Girish S et al. (2011) Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia. Vaccine 29:6941-7
Kumar, Devender; Kirimanjeswara, Girish; Metzger, Dennis W (2011) Intranasal administration of an inactivated Yersinia pestis vaccine with interleukin-12 generates protective immunity against pneumonic plague. Clin Vaccine Immunol 18:1925-35
Durrant, Douglas M; Metzger, Dennis W (2010) Emerging roles of T helper subsets in the pathogenesis of asthma. Immunol Invest 39:526-49
Pangule, Ravindra C; Brooks, Sarah J; Dinu, Cerasela Zoica et al. (2010) Antistaphylococcal nanocomposite films based on enzyme-nanotube conjugates. ACS Nano 4:3993-4000
Sun, Keer; Torres, Luisa; Metzger, Dennis W (2010) A detrimental effect of interleukin-10 on protective pulmonary humoral immunity during primary influenza A virus infection. J Virol 84:5007-14
Durrant, D M; Metzger, D W (2010) IL-12 can alleviate Th17-mediated allergic lung inflammation through induction of pulmonary IL-10 expression. Mucosal Immunol 3:301-11

Showing the most recent 10 out of 36 publications